The Medicines Company announced the launch of a new formulation of Minocin (minocycline) for Injection. The new formulation contains magnesium sulfate, an excipient, which allows for administration at ...
TOKYO, Oct 4, 2022 - (JCN Newswire) - - Eisai Co., Ltd. announced that, as part of the strategic investment towards the realization of its medium-term business plan "EWAY Future & Beyond", it has ...
ProRx Pharma is moving to disrupt one of the fastest-growing corners of the medical wellness industry with the launch of an ...
Stability is a critical factor in drug formulation, with implications for product quality, lifecycle management, and ...
PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for a ...
For the pharmaceutical industry, drug formulation is a cornerstone, crucial for converting bioactive molecules into effective, stable, and patient-friendly medications. For the pharmaceutical industry ...
Credit: Baxter. Zosyn premix is supplied in 2.25g in 50mL, 3.375g in 50mL, and 4.5g in 100mL presentations. Baxter has announced the launch of a frozen premix formulation of Zosyn (piperacillin and ...
(MENAFN- JCN NewsWire) Eisai's Antiepileptic Drug Fycompa Injection Formulation Launched In Japan Addressing Medical Needs for Patients Who Cannot Take the Medication Orally TOKYO, Apr 17, 2024 - (JCN ...
The National Pharmaceutical Pricing Authority (NPPA) has once again extended its mandate to Pune-based Serum Institute of India (SII) to continue manufacturing two of its scheduled formulations ...
Gireesh Babu, New Delhi Wednesday, January 21, 2026, 08:00 Hrs [IST] ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results